Alpha Tau Medical Ltd Ordinary Shares - Class A DRTS 深 滬
等待開盤 08-21 09:30:00 美东时间
3.06
-0.060
-1.92%
華盛通- 最 高3.12
- 今 開3.09
- 成交量 4.78万股
- 最 低 3.05
- 昨 收 3.12
- 總市值 2.59亿
- 52周最高 4.3866
- 市盈率 靜 --
- 換手率 0.06%
- 52周最低 2.11
- 委 比 44.83%
- 總股本 8469.97万
- 歷史最高 20.65
- 量 比 1.05
- 振 幅 2.24%
- 歷史最低 1.75
- 每 手 1
- 風險率 0.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Alpha Tau Medical Q2 EPS $(0.13) Misses $(0.12) Estimate
Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.12) by 13.04 percent. This is a 18.18 percent decrease over losses of $(0.11) per share
08-12 05:26
Alpha Tau Medical GAAP EPS of -$0.22
Alpha Tau Medical press release (NASDAQ:DRTS): Q2 GAAP EPS of -$0.22. As of June 30, 2025, the Company had cash and cash equivalents, short-term deposits and restricted deposits of $83.3 million, comp...
08-12 04:28
Alpha Tau files to sell 3.46M ordinary shares by selling shareholders
Alpha Tau (NASDAQ:DRTS) filed a prospectus to sale 3.46 million ordinary shares. The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder. This prospectus ...
06-24 05:08
Alpha Tau to Present at Jefferies Global Healthcare Conference
<br>Alpha Tau Medical Ltd.'s CFO, Raphi Levy, will present at the Jefferies Global Healthcare Conference on June 5, 2025, in New York, NY. The presentation will occur between 1:25 PM and 1:55 PM ET. Mr. Levy will also be available for individual investor meetings. Alpha Tau, an Israeli oncology company founded in 2016, develops Alpha DaRT<sup>®</sup>, an innovative alpha-radiation therapy for solid tumors. The technology, initially developed by r...
05-28 12:30
Alpha Tau Medical Q1 EPS $(0.12) Beats $(0.13) Estimate
Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 9.09 percent decrease over losses of $(0.11) per share from
05-20 04:02
美股大行评级 | 花旗：维持爱科集团"中性"评级，目标价从95美元升至98美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1108674722736648193.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持Aemetis(AMTX)"买入"评级，目标价从18美元升至19美元</p> <p>• Ascendiant Capital：维持Daxor Corp.(DXR)"买入"评级，目标
03-18 10:15
Alpha Tau Achieves MDSAP Certification, Boosting Global Expansion Efforts
Alpha Tau Medical Ltd ( ($DRTS) ) has issued an update. On February 24, 2025, A...
02-24 21:58
Beam Therapeutics盘中异动 股价大涨5.00%
北京时间2025年01月07日01时34分，Beam Therapeutics Inc.（BEAM.us）股票出现异动，股价快速拉升5.00%。截至发稿，该股报...
01-07 01:34
Alpha Tau to Showcase Innovations at Oncology Symposium
Alpha Tau Medical Ltd (DRTS) has released an update. Alpha Tau Medical Ltd., kn...
2024-12-06 21:59
Alpha Tau Medical Advances in Cancer Treatment Technology
Alpha Tau Medical Ltd (DRTS) has released an update. Alpha Tau Medical Ltd repo...
2024-11-20 05:31
